Atea Pharmaceuticals, Inc. (AVIR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 104K | 0 | 0 | 2.42M | 3.44M | 104K | 19.92M | 104K | 104K | 104K | 18.06M | 16.14M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -104K | 0 | 0 | -2.42M | -3.44M | -104K | -19.92M | -104K | -104K | -104K | -18.06M | -16.14M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 96.98% | 100% | 100% | -2225.96% | -3207.69% | 0% | -10.32% | 99.36% | 99.64% | 99.29% | - | - |
| Operating Expenses | 47.9M | 54.93M | 45.57M | 38.93M | 35.6M | 38.92M | 17.28M | 46.81M | 69.7M | 46.47M | 22.73M | 19.1M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 6.87M | 7.12M | 7.22M | 9.07M | 9.46M | 13.25M | 11.04M | 12.12M | 12.13M | 11.42M | 12.6M | 13.17M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 41.13M | 47.82M | 38.35M | 32.27M | 29.58M | 25.67M | 26.16M | 34.7M | 57.58M | 35.05M | 31.93M | 29.94M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -104K | 0 | 0 | -1000K | -1000K | 0 | -1000K | 0 | 0 | 0 | -1000K | -1000K |
| Operating Income | -48.01M | -54.93M | -45.57M | -41.34M | -39.04M | -39.03M | -37.2M | -46.92M | -69.81M | -46.57M | -40.78M | -35.23M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -22.97% | -40.76% | -22.49% | 11.87% | 44.07% | 16.2% | 8.79% | -33.15% | -67.93% | -16.73% | -150.51% | -9.1% |
| EBITDA | -47.9M | -54.83M | -45.46M | -41.24M | -38.94M | -38.92M | -37.1M | -46.81M | -69.7M | -46.47M | -40.68M | -35.13M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -23.03% | -40.87% | -22.55% | 11.9% | 44.14% | 16.24% | 8.81% | -33.25% | -68.1% | -16.77% | -151.51% | -8.93% |
| D&A (Non-Cash Add-back) | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K | 104K |
| EBIT | -48.01M | -54.93M | -41.85M | -41.42M | -39.04M | -33.32M | -30.97M | -46.92M | -69.81M | -38.81M | -30.66M | -29.31M |
| Net Interest Income | 2.62M | 3.3M | 0 | 4.39M | 4.97M | 5.71M | 6.28M | 6.64M | 6.87M | 7.76M | 7.86M | 7.3M |
| Interest Income | 2.62M | 3.3M | 0 | 4.39M | 4.97M | 5.71M | 6.28M | 6.64M | 6.87M | 7.76M | 7.86M | 7.3M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.62M | 3.3M | 3.71M | 4.39M | 4.97M | 5.71M | 6.28M | 6.64M | 6.87M | 7.76M | 7.86M | 7.3M |
| Pretax Income | -45.39M | -51.63M | -41.85M | -36.95M | -34.07M | -33.32M | -30.93M | -40.28M | -62.94M | -38.81M | -32.92M | -27.93M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 50K | -6.77M | 196K | 207K | 203K | 225K | 226K | 243K | 231K | 349K | 221K | 251K |
| Effective Tax Rate % | -0.11% | 13.11% | -0.47% | -0.56% | -0.6% | -0.68% | -0.73% | -0.6% | -0.37% | -0.9% | -0.67% | -0.9% |
| Net Income | -45.44M | -44.87M | -42.05M | -37.16M | -34.27M | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M | -33.14M | -28.18M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -32.59% | -33.76% | -34.98% | 8.29% | 45.75% | 14.35% | 6.01% | -43.78% | -78.11% | -13.75% | -310.89% | 10.06% |
| Net Income (Continuing) | -45.44M | -44.87M | -42.05M | -37.16M | -34.27M | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M | -33.14M | -28.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | -0.47 | -0.40 | -0.34 |
| EPS Growth % | -42.5% | -42.5% | -43.24% | 8.33% | 46.67% | 14.89% | 7.5% | -41.18% | -74.42% | -14.63% | -312.8% | 10.53% |
| EPS (Basic) | -0.57 | -0.57 | -0.53 | -0.44 | -0.40 | -0.40 | -0.37 | -0.48 | -0.75 | -0.47 | -0.40 | -0.34 |
| Diluted Shares Outstanding | 79.2M | 78.13M | 79.05M | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M |
| Basic Shares Outstanding | 79.2M | 78.13M | 79.05M | 83.75M | 85.16M | 84.46M | 84.42M | 84.25M | 83.92M | 83.44M | 83.4M | 83.4M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |